Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 May 1;155(5):e200087.
doi: 10.1001/jamasurg.2020.0087. Epub 2020 May 20.

Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study

Kathleen M McTigue  1   2 , Robert Wellman  3 , Elizabeth Nauman  4 , Jane Anau  3 , R Yates Coley  3 , Alberto Odor  5 , Julie Tice  6 , Karen J Coleman  7 , Anita Courcoulas  8 , Roy E Pardee  3 , Sengwee Toh  9 , Cheri D Janning  10 , Neely Williams  11   12 , Andrea Cook  3 , Jessica L Sturtevant  9 , Casie Horgan  9 , David Arterburn  3 ; PCORnet Bariatric Study Collaborative
Affiliations
Comparative Study

Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study

Kathleen M McTigue et al. JAMA Surg. .

Abstract

Importance: Bariatric surgery can lead to substantial improvements in type 2 diabetes (T2DM), but outcomes vary across procedures and populations. It is unclear which bariatric procedure has the most benefits for patients with T2DM.

Objective: To evaluate associations of bariatric surgery with T2DM outcomes.

Design, setting, and participants: This cohort study was conducted in 34 US health system sites in the National Patient-Centered Clinical Research Network Bariatric Study. Adult patients with T2DM who had bariatric surgery between January 1, 2005, and September 30, 2015, were included. Data analysis was conducted from April 2017 to August 2019.

Interventions: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).

Main outcome and measures: Type 2 diabetes remission, T2DM relapse, percentage of total weight lost, and change in glycosylated hemoglobin (hemoglobin A1c).

Results: A total of 9710 patients were included (median [interquartile range] follow-up time, 2.7 [2.9] years; 7051 female patients [72.6%]; mean [SD] age, 49.8 [10.5] years; mean [SD] BMI, 49.0 [8.4]; 6040 white patients [72.2%]). Weight loss was significantly greater with RYGB than SG at 1 year (mean difference, 6.3 [95% CI, 5.8-6.7] percentage points) and 5 years (mean difference, 8.1 [95% CI, 6.6-9.6] percentage points). The T2DM remission rate was approximately 10% higher in patients who had RYGB (hazard ratio, 1.10 [95% CI, 1.04-1.16]) than those who had SG. Estimated adjusted cumulative T2DM remission rates for patients who had RYGB and SG were 59.2% (95% CI, 57.7%-60.7%) and 55.9% (95% CI, 53.9%-57.9%), respectively, at 1 year and 86.1% (95% CI, 84.7%-87.3%) and 83.5% (95% CI, 81.6%-85.1%) at 5 years postsurgery. Among 6141 patients who experienced T2DM remission, the subsequent T2DM relapse rate was lower for those who had RYGB than those who had SG (hazard ratio, 0.75 [95% CI, 0.67-0.84]). Estimated relapse rates for those who had RYGB and SG were 8.4% (95% CI, 7.4%-9.3%) and 11.0% (95% CI, 9.6%-12.4%) at 1 year and 33.1% (95% CI, 29.6%-36.5%) and 41.6% (95% CI, 36.8%-46.1%) at 5 years after surgery. At 5 years, compared with baseline, hemoglobin A1c was reduced 0.45 (95% CI, 0.27-0.63) percentage points more for patients who had RYGB vs patients who had SG.

Conclusions and relevance: In this large multicenter study, patients who had RYGB had greater weight loss, a slightly higher T2DM remission rate, less T2DM relapse, and better long-term glycemic control compared with those who had SG. These findings can help inform patient-centered surgical decision-making.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Courcoulas reports grants from Covidien/Ethicon Johnson & Johnson, during the conduct of the study. Dr Tavakkoli reports personal fees from Medtronic and AMAG pharmaceuticals. Dr Jones reports personal fees from Allurion. Mr Nadglowski reports other support from the Obesity Action Coalition outside the submitted work.

Figures

Figure 1.
Figure 1.. Adjusted Total Weight Loss and Change in Hemoglobin A1c Level by Procedure Over 5 Years of Follow-up
Shaded areas represent 95% pointwise CIs for procedure-specific changes in hemoglobin A1c levels. RYGB indicates Roux-en-Y gastric bypass; SG, sleeve gastrectomy.
Figure 2.
Figure 2.. Cumulative Incidence Rates of Type 2 Diabetes Remission and Relapse Across 5 Years in the National Patient-Centered Clinical Research Network Bariatric Study Cohort
Shaded areas represent 95% pointwise CIs for procedure-specific rates. RYGB indicates Roux-en-Y gastric bypass; SG, sleeve gastrectomy.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schauer PR, Bhatt DL, Kirwan JP, et al. ; STAMPEDE Investigators . Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376(7):641-651. doi: 10.1056/NEJMoa1600869 - DOI - PMC - PubMed
    1. Khorgami Z, Shoar S, Saber AA, Howard CA, Danaei G, Sclabas GM. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019;29(3):964-974. doi: 10.1007/s11695-018-3552-x - DOI - PubMed
    1. Jakobsen GS, Småstuen MC, Sandbu R, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA. 2018;319(3):291-301. doi: 10.1001/jama.2017.21055 - DOI - PMC - PubMed
    1. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.e5. doi: 10.1016/j.amjmed.2008.09.041 - DOI - PubMed
    1. Sjöström L, Lindroos AK, Peltonen M, et al. ; Swedish Obese Subjects Study Scientific Group . Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-2693. doi: 10.1056/NEJMoa035622 - DOI - PubMed

Publication types